Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ)
Binzhou, CN
Shandong Sanyuan Biotechnology Co., Ltd., established in 2007 and headquartered in Binzhou, China, specializes in the development, manufacturing, and sale of erythritol and various compound sugar products within the Chinese market. These versatile products find widespread application across numerous industries, serving as ingredients in items such as table and flavored sugars, beverages, candies, chocolate products, baked goods, health foods, pharmaceuticals, cosmetics, and diverse chemical formulations. The company also extends its reach beyond China, distributing its products internationally to regions including Europe, the United States, East Asia, Southeast Asia, Australia, New Zealand, and Africa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.70% | +0.51% | +3.01% | +2.01% | -7.06% | +4.15% | -2.07% | -11.36% | -67.92% | -67.92% | -67.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Food Confectioners: +6.2%-8.9% Q1'26: +49.6% (vs Q1'25)
-
EPS growth Food Confectioners: +8.5%-11.5% Q1'26: +8.3% (vs Q1'25)
-
FCF margin FCF growth · Food Confectioners: +8.1%-8.7% Q1'26: -27.5% (vs Q1'25)
-
EBIT margin Food Confectioners: +8.2%+4.6% Q1'26: +8.0% (vs Q1'25)
-
ROIC Food Confectioners: +7.0%+0.7% Q1'26: +2.0% (vs Q1'25)
-
Share dilution Food Confectioners: +0.0%-1.5% ★ Q1'26: -3.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Food Confectioners: 0.54×0.00× ★ Q1'26: 0.18× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|
| Revenue |
1.65B
est.
|
1.68B
est: 769.18M (+117.8%)
|
674.91M
est: 536.30M (+25.8%)
|
499.50M
est: 536.30M (-6.9%)
|
712.90M
est: 769.82M (-7.4%)
|
649.51M
est: 880.68M (-26.2%)
|
| EBITDA |
391.95M
est.
|
646.27M
est: 183.10M (+253.0%)
|
222.97M
est: 127.67M (+74.7%)
|
118.62M
est: 127.67M (-7.1%)
|
194.67M
est: 213.44M (-8.8%)
|
103.66M
est: 244.17M (-57.5%)
|
| EBIT |
291.00M
est.
|
620.63M
est: 135.94M (+356.5%)
|
184.23M
est: 94.79M (+94.4%)
|
59.01M
est: 94.79M (-37.7%)
|
128.46M
est: 152.14M (-15.6%)
|
30.13M
est: 174.05M (-82.7%)
|
| Net Income |
524.76M
est.
|
535.42M
est: 185.68M (+188.3%)
|
163.69M
est: 74.68M (+119.2%)
|
55.98M
est: 74.68M (-25.0%)
|
104.95M
est: 123.21M (-14.8%)
|
91.41M
est: 158.98M (-42.5%)
|
| SGA |
9.00M
est.
|
18.80M
est: 4.20M (+347.3%)
|
20.30M
est: 2.93M (+592.6%)
|
20.05M
est: 2.93M (+584.3%)
|
25.05M
est: 21.49M (+16.6%)
|
14.92M
est: 24.58M (-39.3%)
|
| EPS |
2.60
est.
|
3.53
est: 0.92 (+283.7%)
|
0.82
est: 0.37 (+121.6%)
|
0.28
est: 0.37 (-24.3%)
|
0.52
est: 0.62 (-16.1%)
|
0.46
est: 0.80 (-42.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.02% | 117.3K | 0.65% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Baohua Cheng | GM & Non Independent Director | — | male |
| Hongfu Wei | Chief Engineer & Director | — | male |
| Hui Hui Li | Accounting Supervisor | — | — |
| Junling Yu | Financial Director | — | female |
| Liang Gao | Board Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 301206.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
